| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.895 | 0.004 | 0.895 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.802 0.004 DBMET03691 | ||
| 0.729 | 0.008 | 0.729 | Angiogenesis inhibitor | 0.562 0.021 DBMET03691 | ||
| 0.675 | 0.004 | 0.675 | EphB2 antagonist | 0.556 0.005 DBMET03691 | ||
| 0.674 | 0.003 | 0.674 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.587 0.009 DBMET03691 | ||
| 0.484 | 0.005 | 0.484 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.481 0.005 DBMET03691 | ||
| 0.46 | 0.005 | 0.46 | Raf kinase inhibitor | 0.46 0.005 DBMET03691 | ||
| 0.439 | 0.008 | 0.439 | RET inhibitor | 0.33 0.017 DBMET03691 | ||
| 0.359 | 0.005 | 0.359 | Granulocyte macrophage colony stimulating factor antagonist | 0.239 0.014 DBMET03691 | ||
| 0.353 | 0.004 | 0.353 | Raf kinase C inhibitor | 0.223 0.008 DBMET03691 | ||
| 0.357 | 0.019 | 0.357 | MAP kinase kinase 2 inhibitor | 0.279 0.042 DBMET03691 | ||
| 0.346 | 0.014 | 0.346 | Vascular endothelial growth factor 3 antagonist | 0.234 0.031 DBMET03691 | ||
| 0.424 | 0.092 | 0.424 | MAP kinase 1 inhibitor | 0.305 0.175 DBMET03691 | ||
| 0.329 | 0.01 | 0.329 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.224 0.019 DBMET03691 | ||
| 0.411 | 0.096 | 0.411 | Beta lactamase inhibitor | |||
| 0.317 | 0.005 | 0.348 | Raf kinase B inhibitor | 0.348 0.005 DBMET03691 | DBMET03691 | |
| 0.404 | 0.108 | 0.404 | Transcription factor inhibitor | |||
| 0.419 | 0.128 | 0.419 | Antiinflammatory | 0.373 0.157 DBMET03691 | ||
| 0.294 | 0.005 | 0.294 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.189 0.009 DBMET03691 | ||
| 0.303 | 0.021 | 0.303 | Vascular endothelial growth factor antagonist | 0.253 0.028 DBMET03691 | ||
| 0.289 | 0.02 | 0.289 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.211 0.039 DBMET03691 | ||
| 0.273 | 0.015 | 0.273 | Ribosomal protein S6 kinase inhibitor | 0.234 0.025 DBMET03691 | ||
| 0.286 | 0.031 | 0.286 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.243 0.049 DBMET03691 | ||
| 0.275 | 0.023 | 0.275 | Vascular endothelial growth factor 2 antagonist | 0.226 0.03 DBMET03691 | ||
| 0.279 | 0.035 | 0.279 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.222 0.056 DBMET03691 | ||
| 0.265 | 0.023 | 0.265 | Tyrosine-protein kinase receptor antagonist | 0.14 0.07 DBMET03691 | ||
| 0.257 | 0.018 | 0.257 | TRKA antagonist | 0.139 0.055 DBMET03691 | ||
| 0.237 | 0.009 | 0.237 | MAP kinase 14 inhibitor | 0.184 0.013 DBMET03691 | ||
| 0.332 | 0.107 | 0.332 | MAP kinase kinase 6 inhibitor | 0.285 0.15 DBMET03691 | ||
| 0.241 | 0.036 | 0.241 | Growth factor agonist | 0.2 0.063 DBMET03691 | ||
| 0.211 | 0.014 | 0.211 | TIE antagonist | 0.113 0.034 DBMET03691 | ||
| 0.207 | 0.013 | 0.207 | TIE-2 antagonist | 0.112 0.033 DBMET03691 | ||
| 0.188 | 0.025 | 0.188 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.166 0.048 DBMET03691 | ||
| 0.222 | 0.061 | 0.222 | Tyrosine kinase inhibitor | 0.127 0.103 DBMET03691 | ||
| 0.185 | 0.027 | 0.185 | MAP kinase 12 inhibitor | 0.13 0.058 DBMET03691 | ||
| 0.211 | 0.062 | 0.211 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.151 0.094 DBMET03691 | ||
| 0.181 | 0.039 | 0.181 | M18 aspartyl aminopeptidase inhibitor | 0.161 0.047 DBMET03691 | ||
| 0.165 | 0.025 | 0.165 | Platelet activating factor alpha antagonist | 0.107 0.054 DBMET03691 | ||
| 0.154 | 0.018 | 0.154 | Stem cell growth factor agonist | 0.103 0.042 DBMET03691 | ||
| 0.222 | 0.091 | 0.222 | Tumour necrosis factor alpha release inhibitor | 0.16 0.145 DBMET03691 | ||
| 0.193 | 0.066 | 0.193 | LIM domain kinase 1 inhibitor | |||
| 0.142 | 0.035 | 0.142 | EphA2 antagonist | 0.117 0.058 DBMET03691 | ||
| 0.13 | 0.023 | 0.13 | p38 MAP kinase inhibitor | 0.096 0.034 DBMET03691 | ||
| 0.182 | 0.078 | 0.182 | TRKC antagonist | |||
| 0.135 | 0.042 | 0.135 | MAP kinase kinase kinase inhibitor | 0.126 0.047 DBMET03691 | ||
| 0.147 | 0.067 | 0.147 | Protein-tyrosine kinase Lyn inhibitor | 0.102 0.1 DBMET03691 | ||
| 0.129 | 0.05 | 0.129 | Vascular endothelial growth factor 1 antagonist | |||
| 0.098 | 0.019 | 0.098 | Cannabinoid CB2 receptor agonist | 0.097 0.02 DBMET03691 | ||
| 0.172 | 0.094 | 0.172 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.133 | 0.059 | 0.133 | TRKB antagonist | 0.102 0.098 DBMET03691 | ||
| 0.124 | 0.053 | 0.124 | Transcription factor STAT6 inhibitor | 0.109 0.082 DBMET03691 | ||
| 0.146 | 0.077 | 0.146 | NOS3 expression enhancer | 0.138 0.086 DBMET03691 | ||
| 0.131 | 0.071 | 0.134 | Interleukin 4 antagonist | 0.134 0.067 DBMET03691 | DBMET03691 | |
| 0.11 | 0.056 | 0.11 | Ephrin antagonist | 0.083 0.081 DBMET03691 | ||
| 0.132 | 0.081 | 0.155 | Protein kinase C nu inhibitor | 0.155 0.067 DBMET03691 | DBMET03691 | |
| 0.169 | 0.119 | 0.176 | Dyrk kinase inhibitor | 0.176 0.113 DBMET03691 | DBMET03691 | |
| 0.155 | 0.109 | 0.155 | Clk dual-specificity kinase inhibitor | 0.138 0.126 DBMET03691 | ||
| 0.11 | 0.066 | 0.11 | MAP kinase 13 inhibitor | |||
| 0.083 | 0.039 | 0.083 | Epoxide hydrolase inhibitor | |||
| 0.121 | 0.084 | 0.121 | Lck kinase inhibitor | |||
| 0.199 | 0.166 | 0.199 | Immunomodulator | |||
| 0.13 | 0.098 | 0.13 | Src kinase inhibitor | |||
| 0.081 | 0.05 | 0.081 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.096 | 0.066 | 0.096 | Platelet activating factor beta antagonist | |||
| 0.06 | 0.032 | 0.06 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.057 0.036 DBMET03691 | ||
| 0.131 | 0.105 | 0.131 | MAP kinase 3 inhibitor | |||
| 0.037 | 0.014 | 0.037 | Cyclophilin A inhibitor | 0.035 0.017 DBMET03691 | ||
| 0.09 | 0.071 | 0.09 | MAP kinase 9 inhibitor | 0.085 0.076 DBMET03691 | ||
| 0.09 | 0.075 | 0.09 | Aurora-A kinase inhibitor | |||
| 0.099 | 0.089 | 0.099 | CDK3/cyclin E inhibitor | |||
| 0.149 | 0.146 | 0.149 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.051 | 0.058 | 0.058 | Cannabinoid receptor agonist | 0.058 0.05 DBMET03691 | DBMET03691 | |
| 0.087 | 0.105 | 0.105 | Protein kinase (CK1) delta inhibitor | 0.105 0.087 DBMET03691 | DBMET03691 | |
| 0.155 | 0.304 | 0.26 | Analgesic | 0.26 0.174 DBMET03691 | DBMET03691 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |